Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Purple Biotech Ltd ADR (NASDAQ: PPBT) was $0.74 for the day, down -8.24% from the previous closing price of $0.81. In other words, the price has decreased by -$8.24 from its previous closing price. On the day, 0.58 million shares were traded. PPBT stock price reached its highest trading level at $0.8526 during the session, while it also had its lowest trading level at $0.7167.
Ratios:
Our analysis of PPBT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PPBT now has a Market Capitalization of 6691562 and an Enterprise Value of 399735776.
Stock Price History:
The Beta on a monthly basis for PPBT is 0.59, which has changed by -0.7124555 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, PPBT has reached a high of $13.95, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 1.79%, while the 200-Day Moving Average is calculated to be -65.29%.
Shares Statistics:
PPBT traded an average of 7.74M shares per day over the past three months and 43873120 shares per day over the past ten days. A total of 9.04M shares are outstanding, with a floating share count of 9.03M. Insiders hold about 0.10% of the company’s shares, while institutions hold 0.54% stake in the company. Shares short for PPBT as of 1760486400 were 61212 with a Short Ratio of 0.01, compared to 1757894400 on 175121. Therefore, it implies a Short% of Shares Outstanding of 61212 and a Short% of Float of 0.6799999999999999.
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.52 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.16 and -$1.16 for the fiscal current year, implying an average EPS of -$1.16. EPS for the following year is -$0.62, with 1.0 analysts recommending between -$0.62 and -$0.62.
